Fagron Publishes Agenda for 2024 Annual Shareholders Meeting and Extraordinary General Meeting
Fagron Publishes Agenda for 2024 Annual Shareholders Meeting and Extraordinary General Meeting
AgendaRegulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 12 April 2024 – 8AM CET
监管信息
拿撒勒（比利时）/鹿特丹（荷兰），2024 年 4 月 12 日 — 欧洲中部时间上午 8 点
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting
法格龙发布2024年年度股东大会和特别股东大会的议程
The Board of Directors of Fagron NV invites shareholders to attend Fagron's annual general meeting of shareholders and the extraordinary general meeting of shareholders on Monday 13 May 2024.
法格龙内华达州董事会邀请股东参加2024年5月13日星期一举行的法格龙年度股东大会和特别股东大会。
Agenda
The agenda includes the discussion of the annual report, the approval of the annual financial statements and the dividend proposal of €0.30 for the financial year 2023, and the approval of the remuneration policy. The remuneration policy provides for an increase in the annual remuneration of the non-executive directors. Furthermore, the agenda includes the proposal to reappoint Robert ten Hoedt as independent, non-executive director. The full agenda and further details can be found in the meeting documents.
议程
议程包括讨论年度报告、批准年度财务报表和2023财年0.30欧元的股息提案，以及薪酬政策的批准。薪酬政策规定增加非执行董事的年度薪酬。此外，该议程还包括重新任命罗伯特·滕·霍特为独立非执行董事的提议。完整的议程和更多细节可以在会议文件中找到。
Meeting and meeting documents
Fagron's annual general meeting of shareholders will be held at its statutory seat, Venecoweg 20A, 9810, Nazareth (Belgium) and by audio and video conference on Monday 13 May 2024 at 3PM CET. Immediately thereafter, the extraordinary general meeting will be held in the presence of associated civil-law notary Stijn Raes.
会议和会议文件
法格龙的年度股东大会将在其法定所在地Venecoweg 20A，9810，拿撒勒（比利时）举行，并将于2024年5月13日星期一下午3点通过音频和视频会议举行。此后，特别股东大会将立即在相关的民法公证人Stijn Raes在场的情况下举行。
The convocation, including the agenda, and other documents related to both general meetings of shareholders can be found on the Fagron website.
会议，包括议程，以及与两次股东大会相关的其他文件可以在Fagron网站上找到。
Further information
Karen Berg
Global Investor Relations Manager
Tel. +31 6 53 44 91 99
karen.berg@fagron.com
进一步的信息
凯伦·伯格
全球投资者关系经理
电话 +31 6 53 44 91 99
karen.berg@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.
关于 Fagron
Fagron 是一家活跃于药物复合领域的全球领先公司，专注于为全球 30 多个国家的医院、药房、诊所和患者提供个性化药物。
Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. Fagron's operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.
比利时公司Fagron NV的注册办事处位于拿撒勒，并在布鲁塞尔泛欧交易所和阿姆斯特丹泛欧交易所上市，股票代码为 “FAGR”。法格隆的运营活动由总部位于鹿特丹的荷兰公司Fagron BV管理。
In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.
如果本新闻稿的英文译本和荷兰语原件之间存在差异，则以后者为准。
Attachment
附件
- Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting
- 法格龙发布2024年年度股东大会和特别股东大会的议程
